Institute for Biomedical Research "Alberto Sols" (IIBm), Spanish National Research Council-Autonomous University of Madrid (CSIC-UAM), 28029 Madrid, Spain.
Rare Diseases Networking Biomedical Research Centre (CIBERER), CIBER, Carlos III Institute of Health, 28029 Madrid, Spain.
Genes (Basel). 2021 Sep 29;12(10):1553. doi: 10.3390/genes12101553.
Insulin-like growth factor 1 (IGF-1) is a peptide hormone belonging to the insulin family of proteins. Almost all of the biological effects of IGF-1 are mediated through binding to its high-affinity tyrosine kinase receptor (IGF1R), a transmembrane receptor belonging to the insulin receptor family. Factors, receptors and IGF-binding proteins form the IGF system, which has multiple roles in mammalian development, adult tissue homeostasis, and aging. Consequently, mutations in genes of the IGF system, including downstream intracellular targets, underlie multiple common pathologies and are associated with multiple rare human diseases. Here we review the contribution of the IGF system to our understanding of the molecular and genetic basis of human hearing loss by describing, (i) the expression patterns of the IGF system in the mammalian inner ear; (ii) downstream signaling of IGF-1 in the hearing organ; (iii) mouse mutations in the IGF system, including upstream regulators and downstream targets of IGF-1 that inform cochlear pathophysiology; and (iv) human mutations in these genes causing hearing loss.
胰岛素样生长因子 1(IGF-1)是一种属于胰岛素家族的蛋白多肽激素。IGF-1 的几乎所有生物学作用都是通过与其高亲和力的酪氨酸激酶受体(IGF1R)结合来介导的,IGF1R 是一种属于胰岛素受体家族的跨膜受体。该因子、受体和 IGF 结合蛋白构成 IGF 系统,该系统在哺乳动物发育、成人组织稳态和衰老中具有多种作用。因此,IGF 系统中的基因突变,包括下游细胞内靶标,是多种常见病理的基础,并与多种罕见人类疾病相关。在这里,我们通过描述(i)IGF 系统在哺乳动物内耳中的表达模式;(ii)IGF-1 在听觉器官中的下游信号转导;(iii)IGF-1 的上游调节剂和下游靶基因的小鼠突变,这些突变可以提供耳蜗病理生理学信息;以及(iv)导致听力损失的这些基因中的人类突变,来综述 IGF 系统对我们理解人类听力损失的分子和遗传基础的贡献。